PMV Pharmaceuticals Inc.

PMVP | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.48

-$0.02 (-1.33%)

At close: Sep 21, 2026, 4:00 PM ET

$1.43

-$0.05 (-3.38%)

Pre-market: Sep 22, 2026, 6:36 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-1.33%

(1D)

Rating

Updated: Aug 12, 2026

20.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $78.66M

1D Range

1.45 1.49

52W Range

1.02 1.88

Valuation (TTM)

PE -1.04

PB 1.10

EV/EBITDA 0.01

Valuation (NTM)

Forward PE N/A

Forward PEG 0.04

Price Target $5

Cash Flow

FCF Yield -90.6%

SBC Adj. FCF Yield -97.8%

SBC Impact -8.0%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y -17.1% | 1.9%

FCF 3Y | 5Y -19.9% | -4.1%

Returns

ROA -91.7%

ROE -78.1%

ROIC -111.1%

Financial Health

Net Cash

$79.21M

Current Ratio 7.70

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

PMV Pharmaceuticals, Inc. operates as a precision oncology company focused on discovering and developing both small molecule and tumor-agnostic therapies to address p53 mutations in cancer patients. T...

Sector Healthcare

Industry Biotechnology

Employees 54

IPO Date Sep 24, 2020

Website www.pmvpharma.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Upside

+237.84%

Buy (2)

Hold (0)

Sell (0)

Analyst Details ➞